Journal of Biochemical and Molecular Toxicology · 2016 · 45 citations · 17 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerApoptosis ModulationApoptosis PharmacologyApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsCancer Cell ApoptosisCell Cycle InhibitionG1 Cell-cycle ArrestG1-s Phase TransitionMitochondrial Membrane Potential CollapseMitochondrial Pathway Of ApoptosisP53-mediated ApoptosisPoly(adp-ribose) Polymerase Inhibition
Costunolide is a sesquiterpene lactone, which possesses potent anti-cancer properties. However, there is little report about its effects on esophageal cancer. In our study, we investigated the effects of costunolide on the cell viability, cell cycle, and apoptosis in human esophageal cancer Eca-109 cells. It was found that costunolide inhibited the growth of Eca-109 cells in a dose-dependent manner, which was associated with the loss of mitochondrial membrane potential (Δψm ) and the production of ROS. Costunolide induced apoptosis of Eca-109 cells as well as cell cycle arrest in G1/S phase by upregulation of P53 and P21. Costunolide triggered apoptosis in esophageal cancer cells via the upregulation of Bax, downregulation of Bcl-2, and significant activation of caspase-3 and poly ADP-ribose polymerase. These effects were markedly abrogated when cells were pretreated with N-acetylcysteine, a specific reactive oxygen specie inhibitor. These results suggest that costunolide is a potential candidate for the treatment of esophageal cancer.
17
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
Free radicals and antioxidants in human health: current status and future prospects.
T.P.A. Devasagayam, Jai C. Tilak, Krutin K Boloor et al. · PubMed · 2004 · 1.6K citations
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel, Francesca Grespi, Waldemar Chmelewskij et al. · APOPTOSIS · 2009 · 327 citations